Clinical Trial Update: This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria [Phase 2]

View source ↗

Summary

A Phase 2 clinical study is evaluating the safety and rapid anti-malarial activity of combining SJ733 with tafenoquine for radical cure of Plasmodium vivax mala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• SJ733 (SJ733)
• Tafenoquine (tafenoquine)

Snippet

Sponsor: R. Kiplin Guy | Conditions: Malaria, Malaria Vivax | Phase 2 | Status: NOT_YET_RECRUITING